Browse > Article
http://dx.doi.org/10.5487/TR.2016.32.4.269

Evaluation of Haemagglutinin Content by RP-HPLC to Generate Pandemic Influenza Vaccine  

Kang, Hyunkyung (Biologics Research Division, National Institute of Food and Drug Safety and Evaluation)
Roh, Hang Sik (Biologics Research Division, National Institute of Food and Drug Safety and Evaluation)
Song, Hyemin (Biologics Research Division, National Institute of Food and Drug Safety and Evaluation)
Lee, Kwangmoon (Biologics Research Division, National Institute of Food and Drug Safety and Evaluation)
Chung, Seung-Tae (Biologics Research Division, National Institute of Food and Drug Safety and Evaluation)
Ban, Sang-ja (Biologics Research Division, National Institute of Food and Drug Safety and Evaluation)
Mo, In Pil (College of Veterinary Medicine, Chungbuk National University)
An, Beum-Soo (Department of Biomaterials Science, College of Natural Resources & Life Science/Life and Industry Convergence Research Institute, Pusan National University)
Ahn, Chi-Young (Biologics Research Division, National Institute of Food and Drug Safety and Evaluation)
Publication Information
Toxicological Research / v.32, no.4, 2016 , pp. 269-274 More about this Journal
Abstract
The potency of influenza vaccine is determined based on its hemagglutinin (HA) content. In general, single radial immunodiffusion (SRID) assay has been utilized as the standard method to measure HA content. However, preparation of reagents for SRID such as antigen and antibody takes approximately 2~3 months, which causes delays in the development of influenza vaccine. Therefore, quantification of HA content by other alternative methods is required. In this study, we measured HA contents of H1N1 antigen and H1N1 influenza vaccine by reverse phase-high performance liquid chromatography (RP-HPLC) methods. The presence of HA1 and HA2 was investigated by silver staining and Western blot assay. In addition, accuracy and repeatability of HA measurement by RP-HPLC were evaluated. Comparison of HA concentration by SRID and RP-HPLC revealed a precise correlation between the two methods. Our results suggest that RP-HPLC assay can replace SRID in the event of a pandemic flu outbreak for rapid vaccine development.
Keywords
Influenza; Hemagglutinin; RP-HPLC; Vaccine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Kitler, M.E., Gavinio, P. and Lavanchy, D. (2002) Influenza and the work of the World Health Organization. Vaccine, 20 Suppl 2, S5-S14.
2 Wood, J.M., Schild, G.C., Newman, R.W. and Seagroatt, V. (1977) An improved single-radial-immunodiffusion technique for the assay of influenza haemagglutinin antigen: application for potency determinations of inactivated whole virus and subunit vaccines. J. Biol. Stand., 5, 237-247.   DOI
3 Willkommen, H., Platen, S. and Staber, H. (1983) The influence of pH and ionic strength on the single radial immunodiffusion test in qualitative assay of influenza virus haemagglutinin. Acta Virol., 27, 407-411.
4 Gerdil, C. (2003) The annual production cycle for influenza vaccine. Vaccine, 21, 1776-1779.   DOI
5 Gerdil, C. (2003) Using the strains and getting the vaccine licensed--a vaccine manufacturer's view. Dev. Biol. (Basel), 115, 17-21.
6 Wood, J.M., Mumford, J., Schild, G.C., Webster, R.G. and Nicholson, K.G. (1986) Single-radial-immunodiffusion potency tests of inactivated influenza vaccines for use in man and animals. Dev. Biol. Stand., 64, 169-177.
7 Kapteyn, J.C., Saidi, M.D., Dijkstra, R., Kars, C., Tjon, J.C., Weverling, G.J., de Vocht, M.L., Kompier, R., van Montfort, B.A., Guichoux, J.Y., Goudsmit, J. and Lagerwerf, F.M. (2006) Haemagglutinin quantification and identification of influenza A&B strains propagated in PER.C6 cells: a novel RP-HPLC method. Vaccine, 24, 3137-3144.   DOI
8 Kapteyn, J.C., Porre, A.M., de Rond, E.J., Hessels, W.B., Tijms, M.A., Kessen, H., Slotboom, A.M., Oerlemans, M.A., Smit, D., van der Linden, J., Schoen, P. and Thus, J.L. (2009) HPLC-based quantification of haemagglutinin in the production of egg- and MDCK cell-derived influenza virus seasonal and pandemic vaccines. Vaccine, 27, 1468-1477.   DOI
9 Lorbetskie, B., Wang, J., Gravel, C., Allen, C., Walsh, M., Rinfret, A., Li, X. and Girard, M. (2011) Optimization and qualification of a quantitative reversed-phase HPLC method for hemagglutinin in influenza preparations and its comparative evaluation with biochemical assays. Vaccine, 29, 3377-3389.   DOI